neuroLytixs
Brain Health For The Next Generation
- Headquarters
- Toronto, Ontario
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- neurolytixs.com
- Total Funding
- $1.1M
- Last Round
- $1.1M Venture Round
About
neuroLytixs is a Canadian biotech and medical technology company developing AI-powered blood-based diagnostic tests for concussion detection in youth and amateur sports. Their proprietary test leverages artificial intelligence to analyze blood metabolites and lipids, achieving up to 96% accuracy in diagnosing concussions within 48 hours. Founded by CEO Peter George, CFO Adrian Uthay, and Chief Medical Officer Dr. Douglas Fraser at Western University, the company aims to revolutionize concussion diagnosis and return-to-play decision-making in organized sports.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account